Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Administrative data (1)
- Arthritis (1)
- Attrition (1)
- Biomarkers (1)
- Chronic Care (1)
-
- Epidemiology (1)
- Goal Setting (1)
- Interstitial lung disease (1)
- Longitudinal (1)
- Mixed connective tissue disease; auto-amputation; ischemia; Raynaud's disease; thromboangiitis obliterans (1)
- Modeling (1)
- Mortality (1)
- Participants (1)
- Patient Activation (1)
- Rheumatic (1)
- Rheumatoid arthritis (1)
- Uric Acid (1)
- Publication
- Publication Type
Articles 1 - 5 of 5
Full-Text Articles in Rheumatology
Multi-Digit Auto-Amputation In Setting Of Mixed Connective Tissue Disease, Kishan P. Patel, Jennifer L. Medlin, Michelene Hearth-Holmes
Multi-Digit Auto-Amputation In Setting Of Mixed Connective Tissue Disease, Kishan P. Patel, Jennifer L. Medlin, Michelene Hearth-Holmes
Graduate Medical Education Research Journal
Raynaud’s disease is a cutaneous manifestation often present in various connective tissue and vascular diseases. Depending on the age of onset and acuity of symptoms, the phenomenon can provide clinicians with some insight as to the severity of underlying disease, including the distinction between primary and secondary Raynaud’s. However, this diagnostic approach seems to have its limitations regarding efficacy and timing of treatment. Traditionally, treatment of Raynaud’s has focused on reestablishing blood perfusion to affected tissue, which has previously been achieved with vasodilatory medications and site-specific surgical intervention. In lieu of the severe sequelae of Raynaud’s in the setting of …
Enhancing The Identification Of Rheumatoid Arthritis-Associated Lung Disease, Bryant England
Enhancing The Identification Of Rheumatoid Arthritis-Associated Lung Disease, Bryant England
Theses & Dissertations
Rheumatoid arthritis (RA) is a systemic autoimmune disease that predisposes afflicted individuals to reduced quality of life, physical disability, and premature mortality. While joint involvement is the primary manifestation of RA, extra-articular features including lung disease are responsible for a significant portion of the excess mortality. In this dissertation I demonstrate the contribution of chronic lung diseases to premature mortality in RA, contrasting with the more widely recognized comorbidity in RA of cardiovascular disease. Then, I establish that a novel serum biomarker, anti-malondialdehyde-acetaldehyde adduct (MAA) antibody, is associated with the presence of interstitial lung disease (ILD) in RA subjects. Further …
Factors Associated With Participant Attrition In A Longitudinal, Survey-Based Rheumatic Disease Databank, Kathryn A. Grafel
Factors Associated With Participant Attrition In A Longitudinal, Survey-Based Rheumatic Disease Databank, Kathryn A. Grafel
Capstone Experience
Introduction: Participant attrition is a problem common to many longitudinal studies, and when it occurs nonrandomly, it can impact the study’s validity and generalizability. Identifying factors associated with attrition can help to detect bias and aid in developing targeted interventions to reduce attrition. Methods: Logistic regression and Cox proportional hazards regression models were constructed separately for patients with rheumatoid arthritis, systemic lupus erythematosus, and other rheumatic diseases who participated in the FORWARD study between 1998 and 2018. Results: Patient characteristics associated with attrition included male sex, younger age, non-White race, and less education, each of which was identified in multiple …
Modifiable Barriers To Optimal Outcomes In Gout Management, Brian W. Coburn
Modifiable Barriers To Optimal Outcomes In Gout Management, Brian W. Coburn
Theses & Dissertations
Improving patient outcomes in chronic disease is of critical importance to the future of health care. Gout, affecting 4% of the US population, is a highly treatable chronic disease from which patients experience unnecessarily suboptimal outcomes. In this dissertation, I demonstrate how interrelated patient and provider factors affect patient outcomes in gout. First, I describe how only 14% of gout patients know their serum urate (SU) goal for urate lowering therapy (ULT) despite otherwise being knowledgeable about gout and its treatment. I then demonstrate the importance of multiple patient and provider factors in achieving SU goal. Specifically, I demonstrate that …
Division Of Rheumatology New Frontiers, Debra Bergman, John Keenan
Division Of Rheumatology New Frontiers, Debra Bergman, John Keenan
New Frontiers
Table of Contents
• Nebraska Arthritis Outcomes Research Center puts UNMC on cutting edge
• Medical education: A fresh perspective
• The reader
• Lupus study becomes international affair
• The puzzle of ‘the loss of self-tolerance’
• An icon in rheumatology
• Registry, research offer insights into RA risk factors
• On the RISE
• RAIN man
• A top-tier team player
• Faculty Publications & Research Awards